FDA Drug recall D-1518-2016
Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corpora…
- FDA Drug
- Class III
- terminated
- Published 2016-09-28
On 2016-09-28 the FDA classified a Class III recall of Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corpora… by Genzyme Genzyme Biosurgery, citing labeling: Incorrect or Missing Lot and/or Exp. Date.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1518-2016 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2016-08-04 |
| Published | 2016-09-28 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Genzyme Genzyme Biosurgery |
| Distribution | US |
Product
Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142 A Sanofi Company Country of Origin : United Kingdom, NDC 0024-5862-01
Reason
Labeling: Incorrect or Missing Lot and/or Exp. Date
Identifiers
| ndc | 0024-5862-01 |
|---|---|
| code_info | Lot # 5RZ002; Exp. 04/18 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1518-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.